Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock

51.05 EUR
-0.45 (-0.87%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 75 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
In the past year AKE had a positive cash flow from operations.
Each year in the past 5 years AKE has been profitable.
In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE has a Return On Assets (1.51%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 2.90%, AKE is in line with its industry, outperforming 53.33% of the companies in the same industry.
The Return On Invested Capital of AKE (3.44%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 7.13%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.22%, AKE is in line with its industry, outperforming 54.67% of the companies in the same industry.
AKE's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.35%, AKE perfoms like the industry average, outperforming 57.33% of the companies in the same industry.
AKE's Operating Margin has declined in the last couple of years.
The Gross Margin of AKE (19.02%) is worse than 73.33% of its industry peers.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for AKE is higher compared to a year ago.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.86 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKE has a Altman-Z score of 1.86. This is in the lower half of the industry: AKE underperforms 73.33% of its industry peers.
AKE has a debt to FCF ratio of 16.70. This is a negative value and a sign of low solvency as AKE would need 16.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.70, AKE is in line with its industry, outperforming 52.00% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.50, AKE perfoms like the industry average, outperforming 42.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.86
ROIC/WACC0.71
WACC4.83%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.73, AKE belongs to the best of the industry, outperforming 82.67% of the companies in the same industry.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.92, AKE belongs to the top of the industry, outperforming 85.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
Looking at the last year, AKE shows a small growth in Revenue. The Revenue has grown by 0.32% in the last year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.13% yearly.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.37% yearly.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.91 indicates a reasonable valuation of AKE.
Based on the Price/Earnings ratio, AKE is valued cheaper than 90.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.50, AKE is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.52, the valuation of AKE can be described as reasonable.
90.67% of the companies in the same industry are more expensive than AKE, based on the Price/Forward Earnings ratio.
AKE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.93.
Industry RankSector Rank
PE 9.91
Fwd PE 9.52
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 94.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 81.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.11
EV/EBITDA 4.44
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

AKE's earnings are expected to decrease with -8.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)101.43
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%

6

5. Dividend

5.1 Amount

AKE has a Yearly Dividend Yield of 6.85%, which is a nice return.
AKE's Dividend Yield is rather good when compared to the industry average which is at 2.58. AKE pays more dividend than 93.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.85%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.80%!
Dividend Growth(5Y)6.8%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (12/23/2025, 7:00:00 PM)

51.05

-0.45 (-0.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners61.12%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.88B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts71.43
Price Target63.94 (25.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.85%
Yearly Dividend3.46
Dividend Growth(5Y)6.8%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-10.29%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-18.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-2.33%
Valuation
Industry RankSector Rank
PE 9.91
Fwd PE 9.52
P/S 0.41
P/FCF 17.11
P/OCF 3.82
P/B 0.54
P/tB 1.81
EV/EBITDA 4.44
EPS(TTM)5.15
EY10.09%
EPS(NY)5.36
Fwd EY10.51%
FCF(TTM)2.98
FCFY5.85%
OCF(TTM)13.36
OCFY26.17%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)101.43
Graham Number104.98
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.86
F-Score5
WACC4.83%
ROIC/WACC0.71
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year43.04%
EBIT Next 3Y16.99%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


What is the valuation status of ARKEMA (AKE.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ARKEMA (AKE.PA) stock?

The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 9.91 and the Price/Book (PB) ratio is 0.54.


How financially healthy is ARKEMA?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.